Table 1 Patients’ characteristics
|  | All (n = 130) | low A-FABP < 18.6 ng/ml (n = 65) | high A-FABP ≥ 18.6 ng/ml (n = 65) | p value (high vs. low) |
|---|---|---|---|---|
A-FABP (ng/ml) | 18.6 (13.8, 27.3) | 14.2 (11.2, 16.8) | 25.6 (22.6, 34.7) | Â |
Age (years) | 72 ± 9 | 72 ± 9 | 71 ± 9 | 0.77 |
Men, n (%) | 105 (81) | 47 (72) | 89 (81) | 0.01 |
Body mass index (kg/m2) | 24.5 ± 3.3 | 23.6 ± 2.8 | 25.4 ± 3.5 | <0.01 |
Hypertension, n (%) | 99 (76) | 51 (78) | 48 (74) | 0.54 |
Dyslipidemia, n (%) | 99 (76) | 50 (77) | 49 (75) | 0.42 |
Diabetes mellitus, n (%) | 65 (50) | 33 (51) | 32 (49) | 0.51 |
Smoking, n (%) | 18 (14) | 9 (14) | 9 (14) | 0.99 |
LDL cholesterol (mg/dl) | 103 ± 28 | 104 ± 25 | 102 ± 31 | 0.64 |
HDL cholesterol (mg/dl) | 43 ± 11 | 41 ± 10 | 44 ± 12 | 0.13 |
Triglycerides (mg/dl) | 141 (102, 181) | 132 (97, 187) | 148 (118, 178) | 0.57 |
Fasting blood sugar (mg/dl) | 99 (92, 119) | 99 (92, 119) | 100 (92, 120) | 0.82 |
Serum creatinine (mg/l) | 0.85 (0.70, 1.00) | 0.86 (0.70, 0.96) | 0.82 (0.71, 1.01) | 0.35 |
HemoglobinA1c (%) | 5.8 (5.3, 6.7) | 5.6 (5.2, 6.6) | 5.9 (5.3, 6.8) | 0.34 |
hsCRP (mg/l) | 0.14 (0.04, 0.36) | 0.11 (0.04, 0.34) | 0.16 (0.06, 0.41) | 0.56 |
Number of diseased vessels | ||||
 One | 56 (43) | 32 (49) | 24 (37) |  |
 Two | 42 (32) | 21 (33) | 21 (32) | 0.21 |
 Three | 32 (25) | 12 (18) | 20 (31) |  |
Medications | ||||
 Antiplatelets | 130 (100) | 65 (100) | 65 (100) | 1.00 |
 ACEIs/ARBs | 70 (54) | 35 (54) | 35 (54) | 0.99 |
 Calcium channel blockers | 64 (49) | 33 (51) | 31 (48) | 0.75 |
 β-blockers | 39 (30) | 16 (25) | 23 (35) | 0.18 |
 Statins | 75 (58) | 40 (62) | 35 (54) | 0.32 |